Amniotics AB (publ)

Amniotics AB (publ)verified

AMNI.ST

Price:

$0.0054

Market Cap:

$14.76M

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.

Industry

Biotechnology

IPO Date

2021-07-06

Stock Exchange

STO

Ticker

AMNI.ST

The Enterprise Value as of November 2025 (TTM) for Amniotics AB (publ) (AMNI.ST) is 9.13M

According to Amniotics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 9.13M. This represents a change of -247.37% compared to the average of -6193079.35 of the last 4 quarters.

Amniotics AB (publ) (AMNI.ST) Historical Enterprise Value (quarterly & annually)

How has AMNI.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Amniotics AB (publ) over the last ten years is 490.08M. The current 9.13M Enterprise Value has changed 86.22% with respect to the historical average. Over the past ten years (40 quarters), AMNI.ST's Enterprise Value was at its highest in in the December 2021 quarter at 336.58M. The Enterprise Value was at its lowest in in the March 2023 quarter at -27372838.54.

Quarterly (TTM)
Annual

Average

490.08M

Median

656.96M

Minimum

19.63M

Maximum

769.07M

Amniotics AB (publ) (AMNI.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amniotics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0.91%

Maximum Annual Enterprise Value = 769.07M

Minimum Annual Increase = -87.17%

Minimum Annual Enterprise Value = 19.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202319.63M-72.29%
202270.82M-87.17%
2021551.82M-28.25%
2020769.07M0.91%
2019762.10M-0.65%

Amniotics AB (publ) (AMNI.ST) Average Enterprise Value

How has AMNI.ST Enterprise Value performed in the past?

The current Enterprise Value of Amniotics AB (publ) (AMNI.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

214.09M

5-year avg

434.69M

10-year avg

490.08M

Amniotics AB (publ) (AMNI.ST) Enterprise Value vs. Peers

How is AMNI.ST’s Enterprise Value compared to its peers?

Amniotics AB (publ)’s Enterprise Value is greater than Idogen AB (publ) (7.48M), greater than Pharmiva AB (publ) (-1197289.00), less than Diagonal Bio AB (publ) (17.46M), greater than Ziccum AB (publ) (7.88M), greater than Cyxone AB (publ) (-9918956.00), greater than Redwood Pharma AB (-1133227.00), greater than Scandion Oncology A/S (-11962465.11), greater than Cline Scientific AB (publ) (570.35K), greater than Asarina Pharma AB (publ) (-1527041.00), greater than Kancera AB (publ) (8.45M),

Build a custom stock screener for Amniotics AB (publ) (AMNI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amniotics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amniotics AB (publ) (AMNI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amniotics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amniotics AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Amniotics AB (publ) (AMNI.ST)?

What is the 3-year average Enterprise Value for Amniotics AB (publ) (AMNI.ST)?

What is the 5-year average Enterprise Value for Amniotics AB (publ) (AMNI.ST)?

How does the current Enterprise Value for Amniotics AB (publ) (AMNI.ST) compare to its historical average?